In The News Posted July 10, 2019 Share Posted July 10, 2019 SINGAPORE, July 10, 2019 /PRNewswire/ -- One BioMed Pte Ltd, a Singapore-based medical diagnostics company, announced today that it has closed a US$5 million Series A financing round, led by Singapore-based Biopath Ventures and US-based ARCH Venture Partners, with Enterprise Singapore's... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.